Budesonide oral - West Pharmaceutical Services

Drug Profile

Budesonide oral - West Pharmaceutical Services

Latest Information Update: 01 Feb 2008

Price : $50

At a glance

  • Originator West Pharmaceutical Services
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Pregnenediones; Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Crohn's disease; Ulcerative colitis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 02 Aug 2004 This compound is still in active development
  • 13 Jun 2001 Phase-I clinical trials for Crohn's disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top